Collaborated effort against SARS-CoV-2 outbreak in China

Qiwen Yang; Yang Zhou; Jingwen Ai; Jinmin Ma; Fenglin Cao; Weifan Cao; Wengeng Zhang; Shifu Wang; Weijun Chen; Xiaoling Ma; Wenhong Zhang; Weimin Li

doi:10.1002/ctm2.7

Collaborated effort against SARS-CoV-2 outbreak in China

Clin Transl Med. 2020 Jan;10(1):13-16. doi: 10.1002/ctm2.7. Epub 2020 Mar 31.

Authors

Qiwen Yang¹, Yang Zhou², Jingwen Ai³, Jinmin Ma⁴, Fenglin Cao⁵, Weifan Cao⁶, Wengeng Zhang⁷, Shifu Wang⁸, Weijun Chen^{2

4}, Xiaoling Ma⁹, Wenhong Zhang³, Weimin Li¹⁰

Affiliations

¹ Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
² BGI PathoGenesis Pharmaceutical Technology Co., Ltd, BGI-Shenzhen, Shenzhen, China.
³ Department of Infectious Disease, Huashan Hospital of Fudan University, Shanghai, China.
⁴ BGI-Shenzhen, Shenzhen, China.
⁵ The Centre Laboratory of Hematological and Oncological, Department, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
⁶ School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong.
⁷ Precision Medicine Center & Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China.
⁸ Department of Children's Medical Laboratory Diagnosis Center, Qilu Children's Hospital of Shandong University, Jinan, China.
⁹ Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.
¹⁰ Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.

PMID: 32508021
PMCID: PMC7285843
DOI: 10.1002/ctm2.7

Abstract

A previously unknown beta coronavirus, SARS-CoV-2, was discovered from a cluster of patients with pneumonia of unknown cause in Wuhan since the end of 2019. Ever since the start of COVID-19, government administrations, academic institutions, and technology enterprises are under unprecedented cooperation in controlling this outbreak from pathogen identification, epidemic situation assessment, to outbreak containment. Timely identification, isolation, and whole-genome sequencing of SARS-CoV-2 have laid the foundation for effective control of this novel infection. With the increasing case numbers worldwide, more real-time information is emerging, changing our understandings to SARS-CoV-2 outbreak, and nonetheless refining the outbreak control responses. The efficient management of COVID-19 requires global collaboration and an efficient share of information.

Keywords: COVID-19; SARS-CoV-2.

Abstract

Grants and funding